
JNJ-9676 is a small-molecule ингибитор targeting the coronavirus M protein. JNJ-9676 has double-digit nanomolar in vitro potency against sarbecoviruses including SARS-CoV, all tested variants of SARS-CoV-2, and bat and pangolin SARS-like coronaviruses.
JNJ-9676 is a small-molecule inhibitor targeting the coronavirus M protein. JNJ-9676 has double-digit nanomolar in vitro potency against sarbecoviruses including SARS-CoV, all tested variants of SARS-CoV-2, and bat and pangolin SARS-like coronaviruses.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.